Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria

[1]  A. Tsuji.  Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2]  T. Terasaki,et al.  Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: An overview of biology and methodology , 2005 .

[3]  Werner Zolg,et al.  Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards , 2004, Proteomics.

[4]  M. Fromm,et al.  Pharmacogenomics of human OATP transporters , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  S. Ohtsuki.  New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. , 2004, Biological & pharmaceutical bulletin.

[6]  D. Sabatini,et al.  CONTROLLED PROTEOLYSIS OF NASCENT POLYPEPTIDES IN RAT LIVER CELL FRACTIONS , 1970, The Journal of cell biology.

[7]  R. Aebersold,et al.  Mass Spectrometry and Protein Analysis , 2006, Science.

[8]  Ruedi Aebersold,et al.  The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.

[9]  Hiroyuki Kaji,et al.  Large-scale identification of Caenorhabditis elegans proteins by multidimensional liquid chromatography-tandem mass spectrometry. , 2003, Journal of proteome research.

[10]  R. Aebersold,et al.  Proteomics: the first decade and beyond , 2003, Nature Genetics.

[11]  Hanno Steen,et al.  Proteomics goes quantitative: measuring protein abundance. , 2002, Trends in biotechnology.

[12]  T. Terasaki,et al.  Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development , 2007, Pharmaceutical Research.

[13]  William S Hancock,et al.  Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system. , 2002, Journal of proteome research.

[14]  M. Taoka,et al.  Large‐scale identification of proteins expressed in mouse embryonic stem cells , 2005, Proteomics.

[15]  Masahiko Watanabe,et al.  Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte‐derived soluble factor(s) , 2004, Journal of neurochemistry.

[16]  Matthias Mann,et al.  Mass spectrometric-based approaches in quantitative proteomics. , 2003, Methods.

[17]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[18]  S. Carr,et al.  Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.

[19]  W. Pardridge,et al.  A One‐Step Procedure for Isolation of Poly(A)+ mRNA from Isolated Brain Capillaries and Endothelial Cells in Culture , 1991, Journal of neurochemistry.

[20]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Ying Huang.  Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy , 2007, Cancer and Metastasis Reviews.

[22]  Per Artursson,et al.  Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.

[23]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[24]  Leigh Anderson,et al.  Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.

[25]  D. Labuda,et al.  Subcellular proteomics of cell differentiation: Quantitative analysis of the plasma membrane proteome of Caco‐2 cells , 2007, Proteomics.

[26]  D. Schrenk,et al.  Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. , 2001, Toxicology.

[27]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[28]  I. Schafer.  Primary Systemic Carnitine Deficiency is Caused by Mutations in a Gene Encoding Sodium-Ion-Dependent Carnitine Transporter , 2001 .

[29]  Yuichi Sugiyama,et al.  Impact of Drug Transporter Studies on Drug Discovery and Development , 2003, Pharmacological Reviews.

[30]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[31]  Henrik Lindberg,et al.  Discovery of biomarker candidates within disease by protein profiling: principles and concepts. , 2005, Journal of proteome research.

[32]  R. Jones.  Principles and concepts , 2004 .

[33]  E. Dratz,et al.  Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. , 2003, Analytical chemistry.

[34]  G. Tsujimoto,et al.  Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter , 1999, Nature Genetics.

[35]  Yuichi Sugiyama,et al.  Transporters as a determinant of drug clearance and tissue distribution. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  M. Mann,et al.  Proteomic characterization of the human centrosome by protein correlation profiling , 2003, Nature.

[37]  Zhen Liu,et al.  Proteomic analysis of rat hippocampal plasma membrane: characterization of potential neuronal‐specific plasma membrane proteins , 2006, Journal of neurochemistry.

[38]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. Pardridge,et al.  Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. , 1990, The Journal of biological chemistry.

[40]  Daniel B. Martin,et al.  Computational prediction of proteotypic peptides for quantitative proteomics , 2007, Nature Biotechnology.

[41]  George G Klee,et al.  Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry. , 2004, Journal of proteome research.

[42]  D. Keppler,et al.  Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.